A skin cancer diagnosis can move quickly from a small spot on the skin to difficult decisions about treatment. When specialists discuss radiotherapy versus immunotherapy, they are not choosing between two interchangeable options. These treatments work in very different ways, may be used at different stages of cancer, and are recommended according to the exact type of skin cancer, where it is located and whether it has spread.

For many early skin cancers, surgery remains the main treatment. But radiotherapy and immunotherapy can be vital when surgery is not suitable, when there is a higher risk of cancer returning, or when melanoma or another skin cancer has travelled beyond its original site. Knowledge can save your life, but it must be paired with timely specialist care.

Radiotherapy versus immunotherapy: the key difference

Radiotherapy uses carefully targeted, high-energy radiation to damage cancer cells in a specific area. It is a local treatment. The aim may be to destroy a tumour, reduce the risk of cancer returning after surgery, or relieve symptoms caused by cancer in a particular part of the body.

Immunotherapy is a medicine that helps the body’s immune system recognise and attack cancer cells. It is a systemic treatment, meaning it travels through the bloodstream and can act on cancer cells in different parts of the body.

That distinction matters. A skin cancer confined to one area may be suited to radiotherapy. Cancer that has spread to lymph nodes, distant organs or several areas of the skin may require immunotherapy, often alongside surgery, radiotherapy or both. The right option is not simply the one with fewer appointments or a shorter-looking side-effect list. It is the one that offers the best balance of cancer control, safety and quality of life for that person.

When radiotherapy may be used for skin cancer

Radiotherapy has an established role in treating several skin cancers, particularly non-melanoma skin cancers such as basal cell carcinoma and squamous cell carcinoma. It may be considered when an operation would be difficult or could cause substantial loss of function or cosmetic change. For example, a cancer on the nose, ear, eyelid or lip can be complex to remove surgically.

It may also be used after surgery when specialists are concerned that microscopic cancer cells could remain, especially in higher-risk squamous cell carcinoma. In some situations, radiotherapy is used to control symptoms from advanced cancer, such as pain, bleeding or pressure on nearby structures.

Treatment is planned by a radiation oncologist. Before treatment begins, the team maps the treatment area and designs a plan intended to target the cancer while limiting radiation to healthy tissue. Sessions are usually delivered over a planned course, which may involve daily visits on weekdays for several weeks, although schedules vary considerably.

Benefits and limits of radiotherapy

A major advantage of radiotherapy is precision. It treats the known cancer site without affecting the whole body in the same way as systemic medicines. It can be particularly useful for people who are not well enough for surgery or whose tumour is in a hard-to-operate area.

However, it is not the best choice for every lesion. Healing may be slower in some areas, and skin changes can develop over time. Depending on the treatment site, side effects can include redness, soreness, peeling, fatigue, hair loss within the treated area and longer-term changes in skin colour or texture. Radiation can also make later surgery more complicated in the same area.

For an early, easily removable skin cancer, surgery may provide the most direct treatment and allow the removed tissue to be examined closely. Your specialist will explain why radiotherapy is, or is not, appropriate in your circumstances.

When immunotherapy may be used for skin cancer

Immunotherapy has transformed treatment for many people with advanced melanoma. It is also used in selected cases of advanced cutaneous squamous cell carcinoma and, less commonly, in other skin cancer settings where standard treatments have not worked or are unsuitable.

Cancer cells can sometimes avoid immune detection. Certain immunotherapy medicines remove some of the biological brakes that normally limit immune activity, allowing immune cells to mount a stronger response against cancer. These medicines are often given through a drip at a hospital or treatment centre, at intervals determined by the drug and treatment plan.

For melanoma, immunotherapy may be recommended after surgery for some people at higher risk of recurrence. It may also be used when melanoma cannot be removed completely or has spread. In selected circumstances, it can be given before surgery to shrink or control disease. These decisions are made by a multidisciplinary team that may include dermatologists, surgeons, medical oncologists, radiation oncologists, pathologists and specialist nurses.

Benefits and limits of immunotherapy

Unlike radiotherapy, immunotherapy can reach cancer cells beyond one visible tumour. Some people have deep and lasting responses, including people with metastatic melanoma who once had very limited treatment options.

Yet immunotherapy does not work for everyone, and responses can be unpredictable. Because it activates the immune system, it can cause the immune system to attack healthy organs. Side effects may involve the skin, bowel, liver, lungs, hormone-producing glands or other parts of the body. Rash, diarrhoea, shortness of breath, unusual tiredness, persistent headache or changes in vision should be reported promptly to the treating team.

Some immune-related side effects are manageable when recognised early, but they can become serious without treatment. Never wait for the next appointment if you feel significantly unwell after immunotherapy. Contact your cancer care team or seek urgent medical help as instructed.

Can radiotherapy and immunotherapy be used together?

Yes, sometimes. A person with advanced melanoma may receive immunotherapy to treat cancer throughout the body and radiotherapy to manage a troublesome tumour in one location, such as a painful bone metastasis or a brain metastasis. In other cases, treatments are sequenced rather than delivered at the same time.

Combining or timing treatments requires careful planning. Specialists consider the cancer type, its location and pace of growth, previous treatments, other medical conditions and the potential for overlapping side effects. Evidence for combinations continues to develop, so the plan should be individualised rather than based on what worked for someone else.

Questions worth asking your treatment team

A cancer consultation can feel overwhelming. Bringing a support person and writing down questions beforehand can help. Ask what type and stage of skin cancer you have, what the treatment is aiming to achieve, and whether surgery remains an option.

It is also reasonable to ask why one treatment is recommended over another, how often you will need appointments, what side effects need urgent attention, and how treatment may affect work, driving, caring responsibilities or travel. If the plan involves immunotherapy, ask who to contact outside business hours if symptoms develop. If it involves radiotherapy, ask how the treated skin should be cared for during and after treatment.

A second opinion can be appropriate when treatment decisions are complex, particularly for advanced melanoma or high-risk squamous cell carcinoma. It should not delay urgent care, but it can help you understand your options with confidence.

Early detection still changes the treatment pathway

Neither radiotherapy nor immunotherapy replaces the value of finding skin cancer early. A changing mole, a new dark or unusual spot, a sore that does not heal, or a scaly patch that repeatedly bleeds needs clinical assessment. Melanoma can occur on skin that receives little sun, including the soles of the feet, under nails and the scalp. People with darker skin can develop skin cancer too, often in areas where it may be missed for longer.

Australia’s UV levels mean regular skin checks are a practical health measure, especially for people with a personal or family history of skin cancer, many moles, past sunburn, outdoor work or frequent recreational sun exposure. Between checks, get to know your own skin and act on change rather than watching and waiting.

If you have been offered radiotherapy or immunotherapy, your next step is not to compare treatments in isolation. Ask your specialist what the recommendation means for your particular cancer, attend every planned appointment, and report new symptoms early. Every minute counts when a suspicious lesion is assessed promptly, and the same principle applies throughout treatment.